PHILADELPHIA — Results of Risperdal trials continue to vary greatly, particularly with the news of the latest one. The jury in Philadelphia’s second Risperdal trial found that the antipsychotic drug’s manufacturers, Johnson & Johnson and Janssen Pharmaceuticals, did fail to warn that gynecomastia, or male breast growth, could result from using Risperdal. However, the jury did not award any damages to the young man, a former Risperdal user, who filed the lawsuit because they failed to find any direct link between the man’s condition and the drug manufacturers’ failure to warn about Risperdal’s side effects.

In the second Philadelphia case, 19-year-old William Cirba alleged that his tennis-ball-sized breasts were the result of his use of Risperdal as a child to treat oppositional defiance disorder. His lawsuit also alleges that Risperdal’s manufacturers promoted the drug for off-label use despite knowing about the risks of its users developing gynecomastia. Although Cirba was not awarded any damages, this case is extremely similar to the first Philadelphia Risperdal trial, in which a young autistic man, Austin Pledger, who had been prescribed Risperdal as a child, was awarded $2.5 million in damages after the jury found that the abnormal development of his breast tissue was the result of using Risperdal. In both cases, the men had taken the antipsychotic drug as children before the FDA actually approved its use in children in 2006. Before then, the drug had only been approved by the FDA to treat schizophrenia in adults. The plaintiff in the second Philadelphia trial may appeal this case in an attempt to get punitive damages because of the negligence of Johnson & Johnson and Janssen Pharmaceuticals.

Even though there were no damages awarded to the plaintiff in the second case, this is still good news for all patients and families of patients who have taken Risperdal. This verdict that J&J and Janssen knew about the risks of Risperdal but still promoted their drug for off-label use is a good precedent for the 1,300 cases that are pending against the Risperdal manufacturers in Pennsylvania alone.

Our Lawyers Can Help

Our dangerous drug attorneys can help if you or someone you care about was harmed by Risperdal. Lawsuits have been filed against the drug maker by both patients and their families seeking compensation for injuries caused by this dangerous drug. You may be entitled to a settlement.

The Risperdal No Fee Promise

If you or a loved one has been harmed by Risperdal, you may have a claim against the manufacturer. Our award winning attorneys specialize in filing lawsuits for people who have been wronged by serious side-effects of prescription medications and defective medical devices. We operate under our No Fee Promise, which means you will not pay a dime until your case has been accepted and you receive your settlement. We will put it in writing for you.

To get started on your case, simply call our offices any time of the day at (866) 280-4722 or fill out the Free Case Review Form on the side of this page. We will listen to your story, explain what rights you have, and determine if you have a potential lawsuit against the device manufacturer. Remember, there are strict time deadlines to filing defective drug and device claims and if you do not act quickly your claim will be lost forever.